Standard Biotools Inc 10-Q for FY2026 Q3
Standard Biotools Inc. (LAB)
10-Q
2026-11-03
For: 2026-09-30
View Original
Added on
November 03, 2026
About this 10-Q
Standard Biotools Inc filed this 10-Q on November 3, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Standard BioTools expects its merger with Treeline Biosciences to close in the fourth quarter of 2026, with existing shareholders holding approximately 16% of the combined company. Stockholders are scheduled to vote on November 19, 2026. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $19.39M
- down 0.9% from $19.55M a year earlier
- Net income
- $13.48M
- compared with a net loss of $34.69M a year earlier
- Diluted EPS
- $0.03
- compared with -$0.09 a year earlier